Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05398120 · ClinicalTrials.gov registry record · NA
Skills Group for Youth at Clinical High-Risk for Psychosis
A NA study of Psychological and Clinical High-Risk, sponsored by University of Pittsburgh.
- Recruiting
- Registry status
- NA
- Development phase
- 30
- Enrollment target
- 1
- Study location
NCT05398120: Recruiting NA study of Psychological and Clinical High-Risk, sponsored by University of Pittsburgh.
NCT05398120 is a NA study of Psychological and Clinical High-Risk that is actively recruiting participants, run by University of Pittsburgh. The registered enrollment target is 30 participants, below the 646-participant average among 9 other Psychological trials with a reported enrollment target (95% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05398120, a NA study of Psychological and Clinical High-Risk, is actively recruiting participants, sponsored by University of Pittsburgh.
- RECRUITING
- Registry status
- NA
- Development phase
- 30 participants
- Enrollment target
- 1
- Study location
Study Summary
This study is intended to test the feasibility of an integrated cognitive behavioral therapy (CBT) and dialectical behavioral therapy (DBT) skills group for adolescents and young adults at clinical high-risk (CHR) for psychosis. The current study applies a skills group drawing from evidence-based practices (e.g., cognitive behavioral therapy (CBT), dialectical behavioral therapy (DBT)) to those at CHR for psychosis. Up to 30 CHR individuals (starting with a minimum of 3 participants, N accounts for attrition as well), aged 13-18, already receiving clinical services within the HOPE team at University of Pittsburgh will be offered a weekly skills group. Data collected on feasibility and outcome measures will occur pre (within 1 month) -post (up to 4-5 months) and half-way (up to 2-3 months) through the intervention. Taken together, the aim of the proposed intervention is to provide novel insights regarding the utility of a newly developed intervention that integrates both CBT and DBT skills for those at CHR for psychosis.
Primary Outcome
Feasibility measure; this will be assessed by recording the number of individuals that discontinued group participation.
Conditions Studied
Interventions
- BEHAVIORAL Skills Group
Study Locations (1)
Pennsylvania
- Bellefield Towers - Pittsburgh
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2022-04-26 |
| Est. Completion | 2026-12-31 |
| Phase | NA |
What NCT05398120 shows while recruiting
NCT05398120 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 30 participants, a relatively small participant target, below the 646-participant average among 9 other Psychological trials with a reported enrollment target (95% lower).
The record links to 2 conditions, with Psychological appearing as the primary indexed condition, and to 1 intervention - of which Skills Group is the first listed.
NCT05398120 reports a single indexed study location in Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT05398120 about?
NCT05398120 is a clinical study titled "Skills Group for Youth at Clinical High-Risk for Psychosis". This study is intended to test the feasibility of an integrated cognitive behavioral therapy (CBT) and dialectical behavioral therapy (DBT) skills group for adolescents and young adults at clinical high-risk (CHR) for psychosis. The current study applies a skills group drawing from evidence-based pr...
What is the current status of trial NCT05398120?
This trial is currently recruiting. It is a NA study. The enrollment target is 30 participants. The study started on 2022-04-26. Estimated completion is 2026-12-31.
What conditions does trial NCT05398120 study?
This clinical trial studies the following conditions: Psychological, Clinical High-Risk.
What interventions are being tested in trial NCT05398120?
The interventions under investigation include: Skills Group (BEHAVIORAL).
Who is sponsoring clinical trial NCT05398120?
This trial is sponsored by University of Pittsburgh, which has 1,238 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05398120 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Psychological
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05398120's enrollment target sits among peer trials
30 8th of 9 higher than 2 of 9 other Psychological trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Psychological trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Smartphone-based Cognitive Emotion Regulation Training for Unpaid Primary Caregivers of Persons With Alzheimer's Disease
RECRUITING · NA
-
A Novel Intervention for Patients With Cancer
RECRUITING · NA
-
Psychobiological Responses Following Exercise and Brain Stimulation
RECRUITING · NA
-
Resilience Coaching for Adolescents With Chronic Musculoskeletal Pain
ACTIVE NOT RECRUITING · NA
-
Harmony & Health: Feasibility of a Movement Intervention to Improve Psychosocial Wellbeing in Black Adults in Northeast Texas
ACTIVE NOT RECRUITING · NA
-
Mindful Motivation for Reducing Binge Eating
ACTIVE NOT RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00977977 · 30 participants · Phase 2
Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy
- NCT01459107 · 30 participants · Phase 2
Human Upper Extremity Allotransplantation
- NCT01666080 · 30 participants · NA
Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)
- NCT01720836 · 30 participants · Phase 1
Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI